U.S. & Puerto Rico was Bausch & Lomb’s largest region in fiscal 2025, bringing in $2.55B of $5.10B (50%).
| Geography | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| U.S. & Puerto Rico | $1.70B | $1.93B | $2.41B | $2.55B | ||
| Other | $616.00M | $655.00M | $712.00M | $777.00M | ||
| China | $343.00M | $344.00M | $358.00M | $358.00M | ||
| France | $195.00M | $210.00M | $227.00M | $246.00M | ||
| Japan | $192.00M | $187.00M | $180.00M | $186.00M | ||
| Germany | $138.00M | $147.00M | $152.00M | $164.00M | ||
| Russia | $132.00M | $106.00M | $120.00M | $148.00M | ||
| United Kingdom | $108.00M | $121.00M | $132.00M | $137.00M | ||
| Canada | $101.00M | $110.00M | $127.00M | $135.00M | ||
| Spain | $77.00M | $85.00M | $92.00M | $101.00M | ||
| Italy | $72.00M | $82.00M | $91.00M | $102.00M | ||
| Mexico | $55.00M | $68.00M | $75.00M | $75.00M | ||
| Poland | $44.00M | $51.00M | $65.00M | $75.00M | ||
| South Korea | — | $46.00M | $47.00M | $51.00M | ||
| Ukraine | — | — | — | — | ||
| Belarus | — | — | — | — | ||
| Total | $3.77B | $4.15B | $4.79B | $5.10B |
Bausch & Lomb brought in $5.10B from its 14 regions in fiscal 2025, the year ended December 31, 2025. That was up 6.5% from $4.79B in fiscal 2024. U.S. & Puerto Rico was the largest at $2.55B (49.9%), ahead of Other at $777.00M (15.2%) and China at $358.00M (7.0%). The other 11 regions brought in $1.42B combined.
Compared with fiscal 2024, Russia grew fastest, up 23.3% to $148.00M. Every region above 2% of revenue grew.
Vision Care was Bausch & Lomb’s largest segment in fiscal 2025, bringing in $1.83B of $3.80B (48%).
| Segment | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Vision Care | $866.00M | $888.00M | $1.72B | $1.83B | ||
| Surgical | $718.00M | $767.00M | $837.00M | $894.00M | ||
| Pharmaceuticals | $681.00M | $836.00M | $965.00M | $1.08B | ||
| Ophthalmic Pharmaceuticals | — | — | — | — | ||
| Total | $2.27B | $2.49B | $3.53B | $3.80B |
Bausch & Lomb brought in $3.80B from its three segments in fiscal 2025, the year ended December 31, 2025. That is less than the $5.10B it reports by geography, so these segments do not cover all of its revenue. Vision Care was the largest at $1.83B (48.2%), ahead of Pharmaceuticals at $1.08B (28.3%) and Surgical at $894.00M (23.5%).
Compared with fiscal 2024, Pharmaceuticals grew fastest, up 11.5% to $1.08B. Every segment above 2% of revenue grew.
Otc was Bausch & Lomb’s largest product and service line in fiscal 2021, bringing in $1.39B of $3.09B (45%).
| Product and Service | FY 2020 | FY 2021 |
|---|---|---|
| Otc | $1.31B | $1.39B |
| Pharmaceuticals | $1.01B | $496.00M |
| Devices | $562.00M | $890.00M |
| Branded & Other Generics | $471.00M | $285.00M |
| Other Revenues | $31.00M | $28.00M |
| Total | $3.38B | $3.09B |
Bausch & Lomb brought in $3.09B from its five product and service lines in fiscal 2021, the year ended December 31, 2021. That was down 8.5% from $3.38B in fiscal 2020. Otc was the largest at $1.39B (45.1%), ahead of Devices at $890.00M (28.8%) and Pharmaceuticals at $496.00M (16.0%). The other two lines brought in $313.00M combined.
Compared with fiscal 2020, Devices grew fastest, up 58.4% to $890.00M, while Pharmaceuticals fell the most, down 50.6% to $496.00M.
Bausch & Lomb (BLCO) reports its revenue by geography, by segment and by product and service. In fiscal 2025, U.S. & Puerto Rico was its largest region, bringing in $2.55B (49.9% of the total), followed by Other at $777.00M (15.2%).
U.S. & Puerto Rico was Bausch & Lomb's largest region in fiscal 2025, bringing in $2.55B, or 49.9% of the $5.10B total across its 14 regions.
Vision Care was Bausch & Lomb's largest segment in fiscal 2025, bringing in $1.83B, or 48.2% of the $3.80B total across its three segments.
Otc was Bausch & Lomb's largest product and service line in fiscal 2021, bringing in $1.39B, or 45.1% of the $3.09B total across its five product and service lines.
Among Bausch & Lomb's regions that make up at least 2% of revenue, Russia grew fastest in fiscal 2025, up 23.3% from $120.00M to $148.00M.
Every figure comes from Bausch & Lomb's annual financial filings, as reported. Each line keeps the name Bausch & Lomb gives it, and years follow its fiscal calendar.
Bausch & Lomb's revenue by geography goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.